Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 2
2010 1
2011 1
2012 1
2013 2
2014 6
2015 1
2016 3
2017 1
2018 4
2019 3
2020 3
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy.
Minenkova O, Santapaola D, Milazzo FM, Anastasi AM, Battistuzzi G, Chiapparino C, Rosi A, Gritti G, Borleri G, Rambaldi A, Dental C, Viollet C, Pagano B, Salvini L, Marra E, Luberto L, Rossi A, Riccio A, Merlo Pich E, Santoro MG, De Santis R. Minenkova O, et al. Among authors: milazzo fm. Mol Ther. 2022 May 4;30(5):1979-1993. doi: 10.1016/j.ymthe.2022.02.013. Epub 2022 Feb 12. Mol Ther. 2022. PMID: 35167974 Free PMC article.
Novel Benzazole Derivatives Endowed with Potent Antiheparanase Activity.
Madia VN, Messore A, Pescatori L, Saccoliti F, Tudino V, De Leo A, Bortolami M, Scipione L, Costi R, Rivara S, Scalvini L, Mor M, Ferrara FF, Pavoni E, Roscilli G, Cassinelli G, Milazzo FM, Battistuzzi G, Di Santo R, Giannini G. Madia VN, et al. Among authors: milazzo fm. J Med Chem. 2018 Aug 9;61(15):6918-6936. doi: 10.1021/acs.jmedchem.8b00908. Epub 2018 Jul 30. J Med Chem. 2018. PMID: 30010344
Spike mutation resilient scFv76 antibody counteracts SARS-CoV-2 lung damage upon aerosol delivery.
Milazzo FM, Chaves-Sanjuan A, Minenkova O, Santapaola D, Anastasi AM, Battistuzzi G, Chiapparino C, Rosi A, Merlo Pich E, Albertoni C, Marra E, Luberto L, Viollet C, Spagnoli LG, Riccio A, Rossi A, Santoro MG, Ballabio F, Paissoni C, Camilloni C, Bolognesi M, De Santis R. Milazzo FM, et al. Mol Ther. 2023 Feb 1;31(2):362-373. doi: 10.1016/j.ymthe.2022.09.010. Epub 2022 Sep 15. Mol Ther. 2023. PMID: 36114671 Free PMC article.
Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity.
Messore A, Madia VN, Pescatori L, Saccoliti F, Tudino V, De Leo A, Bortolami M, De Vita D, Scipione L, Pepi F, Costi R, Rivara S, Scalvini L, Mor M, Ferrara FF, Pavoni E, Roscilli G, Cassinelli G, Milazzo FM, Battistuzzi G, Di Santo R, Giannini G. Messore A, et al. Among authors: milazzo fm. J Med Chem. 2018 Dec 13;61(23):10834-10859. doi: 10.1021/acs.jmedchem.8b01497. Epub 2018 Nov 29. J Med Chem. 2018. PMID: 30412404 Free article.
New classes of potent heparanase inhibitors from ligand-based virtual screening.
Pala D, Scalvini L, Elisi GM, Lodola A, Mor M, Spadoni G, Ferrara FF, Pavoni E, Roscilli G, Milazzo FM, Battistuzzi G, Rivara S, Giannini G. Pala D, et al. Among authors: milazzo fm. J Enzyme Inhib Med Chem. 2020 Dec;35(1):1685-1696. doi: 10.1080/14756366.2020.1811701. J Enzyme Inhib Med Chem. 2020. PMID: 32907434 Free PMC article.
Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors.
Bargiotti A, Musso L, Dallavalle S, Merlini L, Gallo G, Ciacci A, Giannini G, Cabri W, Penco S, Vesci L, Castorina M, Milazzo FM, Cervoni ML, Barbarino M, Pisano C, Giommarelli C, Zuco V, De Cesare M, Zunino F. Bargiotti A, et al. Among authors: milazzo fm. Eur J Med Chem. 2012 Jul;53:64-75. doi: 10.1016/j.ejmech.2012.03.036. Epub 2012 Mar 28. Eur J Med Chem. 2012. PMID: 22538015
29 results